Iatrogenix Launches Companion Support Model for Neurological Care

New company aims to address gap between clinical efficacy and real-world persistence of neurological treatments

Published on Feb. 9, 2026

Got story updates? Submit your updates here. ›

Iatrogenix, a clinician-founded company, has launched a structured model designed to support patients with neurological conditions as they navigate the functional demands of treatment between medical appointments. The company's approach acknowledges that modern treatments can alter physiology, and patients benefit from support in sustaining engagement with those changes. Iatrogenix's programs provide context, frameworks, and scaffolding to help patients tolerate care long enough for outcomes to develop, addressing a recognized vulnerability in modern care delivery.

Why it matters

Patients with neurological conditions often disengage from appropriate medical treatment not because interventions fail clinically, but because the experience of living with those interventions becomes unsustainable in daily life. This disconnect between clinical efficacy and real-world persistence carries measurable consequences for patients, clinicians, and the healthcare system. Iatrogenix's model aims to address this gap by providing complementary infrastructure to support patients between clinical encounters.

The details

Iatrogenix's programs are condition-focused, education-forward structures that include neuro-nutritional formulas as one component within a broader support framework. The model is designed to extend to additional neurological conditions where physiological shifts related to treatment may undermine long-term engagement if unsupported. The approach centers on the observation that modern medicine has advanced therapeutic capability while investing less in infrastructure supporting lived patient experience.

  • Iatrogenix launched its initial programs in February 2026.

The players

Iatrogenix

A clinician-founded company that has launched a structured model designed to support patients with neurological conditions as they navigate the functional demands of treatment between medical appointments.

Dr. Nicholas Tzikas

A board-certified physician with fellowship training in headache neurology who has co-directed a university-based headache and facial pain program and provides scientific oversight for Iatrogenix.

Got photos? Submit your photos here. ›

What they’re saying

“Patients often disengage from appropriate medical treatment not because interventions fail clinically, but because the experience of living with those interventions becomes unsustainable in daily life.”

— Dr. Nicholas Tzikas, Board-certified physician with fellowship training in headache neurology (Iatrogenix)

What’s next

Iatrogenix plans to expand its support programs to additional neurological conditions beyond its initial focus on migraine and mental clarity.

The takeaway

Iatrogenix's model acknowledges a critical gap in modern healthcare delivery, where advances in therapeutic options are not always matched by infrastructure supporting patients' lived experiences with those treatments. By providing complementary support between clinical encounters, the company aims to improve long-term engagement and outcomes for patients managing neurological conditions.